Glass recovery and production of manufactured aggregate from MSWI bottom ashes from fluidized bed and grate incineration by means of enhanced treatment.

Enhanced treatment of incineration bottom ashes (IBA) from municipal solid waste incineration can contribute to a circular economy since not only metals can be recovered but also glass for recycling. Moreover, the remaining mineral fraction can be utilized in concrete as manufactured aggregate. To evaluate the effects of an enhanced treatment, three IBAs from fluidized bed combustion (FB-IBAs) and three grate incineration bottom ashes (G-IBAs) were standardly treated in a jig and further processed on a pilot scale, including improved metal recovery and sensor-based glass separation. The removed glass fractions were weighed and their composition was assessed by means of manual sorting. The manufactured aggregate was also sorted manually and its total and leachate contents were determined before and after aging. Results showed general differences between FB-IBAs and G-IBAs. For G-IBAs, higher contents of heavy metals and residual metal pieces were determined, while the share of glass removed was low compared to FB-IBA. The treated mineral fractions from G-IBA contained more mineral agglomerates, whereas FB-IBAs contained more glass. However, the glass-fractions removed from FB-IBAs need further treatment to be accepted in glass recycling. Austrian limit values for utilization in concrete were met by all manufactured aggregates produced from FB-IBA, but only by one from G-IBA. Overall, the enhanced treatment in the study performed well compared to the literature. Nevertheless, further investigations are necessary to improve the recyclability of the recovered glass fractions and to determine the technical suitability of manufactured aggregates produced from IBAs.

Comparing the quantity and quality of glass, metals, and minerals present in waste incineration bottom ashes from a fluidized bed and a grate incinerator.

Bottom ash is the primary solid residue arising from municipal solid waste incineration. It consists of valuable materials such as minerals, metals and glass. Recovering these materials from bottom ash becomes evident when integrating Waste-to-Energy within the circular economy strategy. To assess the recycling potential from bottom ash, detailed knowledge of its characteristics and composition is required. The study at hand aims to compare the quantity and quality of recyclable materials present in bottom ash from a fluidized bed combustion plant and a grate incinerator, both located in the same city in Austria and receiving mainly municipal solid waste. The investigated properties of the bottom ash are grain-size distribution, contents of recyclable metals, glass, and minerals in different grain size fractions, and the total and leaching contents of substances in minerals. The study results reveal that most recyclables present are of better quality for the bottom ash arising at the fluidized bed combustion plant. Metals are less corroded, glass contains fewer impurities, minerals contain fewer heavy metals, and their leaching behavior is also favorable. Furthermore, recoverable materials, such as metals and glass are more isolated and not incorporated into agglomerates as observed in grate incineration bottom ash. Based on the input to the incinerators more aluminum and significantly more glass can potentially be recovered from bottom ash from fluidized bed combustion. On the downside, fluidized bed combustion produces about five times more fly ash per unit of waste incinerated, which is currently disposed of in landfills.

Neutralization of SARS-CoV-2 Omicron by BNT162b2 mRNA vaccine-elicited human sera.

The globally circulating severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant of concern Omicron (B.1.1.529) has a large number of mutations, especially in the spike protein, indicating that recognition by neutralizing antibodies may be compromised. We tested Wuhan (Wuhan-Hu-1 reference strain), Beta (B.1.351), Delta (B.1.617.2), or Omicron pseudoviruses with sera of 51 participants who received two or three doses of the messenger RNA (mRNA)-based COVID-19 vaccine BNT162b2. After two doses, Omicron-neutralizing titers were reduced >22-fold compared with Wuhan-neutralizing titers. One month after the third vaccine dose, Omicron-neutralizing titers were increased 23-fold relative to their levels after two doses and were similar to levels of Wuhan-neutralizing titers after two doses. The requirement of a third vaccine dose to effectively neutralize Omicron was confirmed with sera from a subset of participants using live SARS-CoV-2. These data suggest that three doses of the mRNA vaccine BNT162b2 may protect against Omicron-mediated COVID-19.

Neutralization of SARS-CoV-2 lineage B.1.1.7 pseudovirus by BNT162b2 vaccine-elicited human sera.

Recently, a new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) lineage called B.1.1.7 (variant of concern: VOC 202012/01), which is reported to spread more efficiently and faster than other strains, emerged in the United Kingdom. This variant has an unusually large number of mutations, with 10 amino acid changes in the spike (S) protein, raising concerns that its recognition by neutralizing antibodies may be affected. In this study, we tested SARS-CoV-2-S pseudoviruses bearing either the Wuhan reference strain or the B.1.1.7 lineage spike protein with sera of 40 participants who were vaccinated in a previously reported trial with the messenger RNA-based COVID-19 vaccine BNT162b2. The immune sera had slightly reduced but overall largely preserved neutralizing titers against the B.1.1.7 lineage pseudovirus. These data indicate that the B.1.1.7 lineage will not escape BNT162b2-mediated protection.